These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2344986

  • 1. [Therapeutic approaches to Wilson's disease].
    Meiner Z.
    Harefuah; 1990 Mar 01; 118(5):296-8. PubMed ID: 2344986
    [No Abstract] [Full Text] [Related]

  • 2. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC.
    Am J Gastroenterol; 1995 Jun 01; 90(6):1026. PubMed ID: 7771405
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Wilson's disease].
    Hoogenraad TU, van Hattum J.
    Dtsch Med Wochenschr; 1987 Jun 05; 112(23):942-3. PubMed ID: 3582206
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F, Cardin R, Mestriner C, Sturniolo GC, Naccarato R.
    Am J Gastroenterol; 1995 Dec 05; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP, Tauxe WN, McCall JT, Gross JB, Randall RV.
    Trans Am Neurol Assoc; 1969 Dec 05; 94():34-7. PubMed ID: 5374484
    [No Abstract] [Full Text] [Related]

  • 6. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K, Siegemund R, Lössner J, Kühn HJ.
    Radiobiol Radiother (Berl); 1988 Dec 05; 29(2):226-9. PubMed ID: 3399664
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L, Campanella G, D'Addabbo A.
    Acta Neurol (Napoli); 1971 Dec 05; 26(4):423-35. PubMed ID: 5132824
    [No Abstract] [Full Text] [Related]

  • 9. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G, Keidl E, Hütteroth T, Dormeyer HH, Manns M, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1985 Jan 05; 23(1):25-9. PubMed ID: 4060799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pathogenesis and treatment of Wilson's disease].
    Nagy J, Vincze Z, Folhoffer A, Horváth A, Csák T, Zelkó R.
    Acta Pharm Hung; 2003 Jan 05; 73(4):237-41. PubMed ID: 15279036
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V, Di Leo V, Lamboglia F, Bowlus CL, Tseng SC, D'Incà R, Irato P, Burra P, Martines D, Sturniolo GC.
    Scand J Gastroenterol; 2007 Dec 05; 42(12):1495-500. PubMed ID: 17994470
    [Abstract] [Full Text] [Related]

  • 15. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
    Alexiou D, Hatzis T, Koutselinis A.
    Arch Fr Pediatr; 1985 Dec 05; 42(6):447-9. PubMed ID: 4051676
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of oral zinc therapy as an alternative to penicillamine for Wilson's disease.
    Cossack ZT.
    N Engl J Med; 1988 Feb 04; 318(5):322-3. PubMed ID: 3336426
    [No Abstract] [Full Text] [Related]

  • 17. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A, Curiel B, Berkowitz D, Levine A, Sack J, Lorberboym M.
    J Pediatr; 2008 Dec 04; 153(6):864-6. PubMed ID: 19014823
    [Abstract] [Full Text] [Related]

  • 18. The treatment of Wilson's disease in paediatrics: oral zinc therapy versus penicillamine.
    Cossack ZT, Bouquet J.
    Acta Pharmacol Toxicol (Copenh); 1986 Dec 04; 59 Suppl 7():514-7. PubMed ID: 3776618
    [No Abstract] [Full Text] [Related]

  • 19. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC.
    J Lab Clin Med; 2003 Jun 04; 141(6):372-7. PubMed ID: 12819634
    [Abstract] [Full Text] [Related]

  • 20. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb 04; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.